United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News EC approves Novartis’ skin cancer therapy combo Tafinlar and Mekinist for melanoma In a significant development for melanoma treatment, the European Commission (EC) has granted Novartis approval for its combination… bypharmanewsdailySeptember 1, 2018
